ES554463A0 - Un procedimiento para la preparacion de un compuesto. - Google Patents

Un procedimiento para la preparacion de un compuesto.

Info

Publication number: ES554463A0
Authority: ES; Spain
Prior art keywords: substituted; group; alkyl; arylalkyl; phenyl
Prior art date: 1985-04-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

ES554463A

Other languages

English (en)

Other versions

ES8801833A1 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-04-30

Filing date

1986-04-28

Publication date

1988-02-16

1986-04-28 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

1988-02-16 Publication of ES8801833A1 publication Critical patent/ES8801833A1/es

1988-02-16 Publication of ES554463A0 publication Critical patent/ES554463A0/es

Status Expired legal-status Critical Current

Links

150000001875 compounds Chemical class 0.000 title abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 17
229910052739 hydrogen Inorganic materials 0.000 abstract 10
239000001257 hydrogen Substances 0.000 abstract 10
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 9
125000003710 aryl alkyl group Chemical group 0.000 abstract 8
150000002431 hydrogen Chemical group 0.000 abstract 8
125000000547 substituted alkyl group Chemical group 0.000 abstract 8
-1 bicyclic pyrazolidinone compound Chemical class 0.000 abstract 5
125000002252 acyl group Chemical group 0.000 abstract 3
150000001767 cationic compounds Chemical class 0.000 abstract 3
229910001411 inorganic cation Inorganic materials 0.000 abstract 3
150000002892 organic cations Chemical class 0.000 abstract 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
125000000623 heterocyclic group Chemical group 0.000 abstract 2
231100000252 nontoxic Toxicity 0.000 abstract 2
230000003000 nontoxic effect Effects 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
208000035143 Bacterial infection Diseases 0.000 abstract 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
230000000845 anti-microbial effect Effects 0.000 abstract 1
239000004599 antimicrobial Substances 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
125000001246 bromo group Chemical group Br* 0.000 abstract 1
150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
125000001309 chloro group Chemical group Cl* 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
125000001153 fluoro group Chemical group F* 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
125000002346 iodo group Chemical group I* 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000005544 phthalimido group Chemical group 0.000 abstract 1
125000006239 protecting group Chemical group 0.000 abstract 1
NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000004953 trihalomethyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Medicinal Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

ES554463A 1985-04-30 1986-04-28 Un procedimiento para la preparacion de un compuesto. Expired ES8801833A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US72902185A	1985-04-30	1985-04-30

Publications (2)

Publication Number	Publication Date
ES8801833A1 ES8801833A1 (es)	1988-02-16
ES554463A0 true ES554463A0 (es)	1988-02-16

Family

ID=24929253

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES554463A Expired ES8801833A1 (es)	1985-04-30	1986-04-28	Un procedimiento para la preparacion de un compuesto.

Country Status (16)

Country	Link
US (4)	US4716232A (es)
EP (1)	EP0202046B1 (es)
JP (2)	JPH0759582B2 (es)
KR (1)	KR880001092B1 (es)
CN (1)	CN86103619A (es)
AT (1)	ATE60605T1 (es)
AU (1)	AU5675586A (es)
CA (1)	CA1274832A (es)
DE (1)	DE3677253D1 (es)
DK (1)	DK193086A (es)
ES (1)	ES8801833A1 (es)
GR (1)	GR861118B (es)
HU (1)	HUT40660A (es)
IL (1)	IL78634A0 (es)
PT (1)	PT82468B (es)
ZA (2)	ZA863170B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3677253D1 (de) *	1985-04-30	1991-03-07	Lilly Co Eli	7-substituierte bicyclische pyrazolidinone.
US4940718A (en) *	1985-04-30	1990-07-10	Eli Lilly And Company	7-substituted bicyclic pyrazolidinones, pharmaceutical compositions and use
US4935536A (en) *	1987-05-21	1990-06-19	Millipore Corporation	Protecting groups for asparagine and glutamine in peptide synthesis
IL86095A0 (es) *	1987-09-30	1988-09-30	Lilly Co Eli
US5011938A (en) *	1989-10-02	1991-04-30	Eli Lilly And Company	7-substituted bicyclic pyrazolidinones
US5430145A (en) *	1990-10-18	1995-07-04	Merrell Dow Pharmaceuticals Inc.	Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5308841A (en) *	1990-12-21	1994-05-03	Merrell Dow Pharmaceuticals Inc.	Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
US5457196A (en) *	1991-09-27	1995-10-10	Merrell Dow Pharmaceuticals Inc.	2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
EP0534363B1 (en) *	1991-09-27	1997-07-09	Merrell Pharmaceuticals Inc.	Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5455242A (en) *	1991-09-27	1995-10-03	Merrell Dow Pharmaceuticals Inc.	Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
DE69317764T2 (de) *	1992-02-14	1998-07-30	Merrell Pharmaceuticals Inc., Cincinnati, Ohio	Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
WO1993023403A1 (en) *	1992-05-15	1993-11-25	Merrell Dow Pharmaceuticals Inc.	NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
US5420271A (en) *	1992-08-24	1995-05-30	Merrell Dow Pharmaceuticals, Inc.	2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
CA2107644A1 (en) *	1992-10-28	1994-04-29	David R. Magnin	.alpha.-phosphonosulfonae squalene synthetase inhibitors and methd
US5470845A (en) *	1992-10-28	1995-11-28	Bristol-Myers Squibb Company	Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia
AU673857B2 (en) *	1992-10-30	1996-11-28	Aventisub Ii Inc.	Mercaptoacetylamide bicyclic lactam derivatives
EP0746566A1 (en) *	1994-02-14	1996-12-11	Merrell Pharmaceuticals Inc.	Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
JPH09508906A (ja) *	1994-02-14	1997-09-09	メレルファーマスーティカルズインコーポレーテッド	エンケファリナーゼ及びａｃｅの阻害剤として有用な新規なメルカプトアセチルアミド１，３，４，５−テトラヒドロベンゾ［ｃ］アゼピン−３−オンジスルフィド誘導体類
HUT74584A (en) *	1994-02-14	1997-01-28	Merrell Pharma Inc	Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them
CA2183320C (en) *	1994-02-14	1999-10-26	Gary A. Flynn	Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
US5530013A (en) *	1994-02-14	1996-06-25	American Home Products Corporation	Venlafaxine in the inducement of cognition enhancement
US5484783A (en) *	1994-03-24	1996-01-16	Merrell Dow Pharmaceuticals Inc.	Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
WO1995025532A1 (en) *	1994-03-24	1995-09-28	Merrell Pharmaceuticals Inc.	Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives
AU688012B2 (en) *	1994-03-24	1998-03-05	Merrell Pharmaceuticals Inc.	Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives
US5447922A (en) *	1994-08-24	1995-09-05	Bristol-Myers Squibb Company	α-phosphonosulfinic squalene synthetase inhibitors
US5786448A (en) *	1996-11-07	1998-07-28	Trega Biosciences, Inc.	Combinatorial libraries of cyclic urea and cyclic thiourea derivatives and compounds therein
GB0119305D0 (en)	2001-04-12	2001-10-03	Aventis Pharma Gmbh	Mercaptoacetylamide derivatives,a process for their preparation and their use
UY32826A (es)	2009-08-04	2011-02-28	Takeda Pharmaceutical	Compuestos heterocíclicos
CN106883236B (zh) *	2017-03-17	2018-12-04	浙江大学	一种制备含硫的n，n-双环吡唑烷酮类衍生物的方法
CN115286635B (zh) *	2022-08-22	2023-10-24	河南师范大学	一种手性并环吡唑啉酮类化合物的合成方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3065224A (en)	1955-06-24	1962-11-20	Bayer Ag	Process for the production of addition products of organic isocyanates and organic carbodiimides
US2938892A (en)	1958-10-10	1960-05-31	Little Inc A	Amides and process of preparing same with a monocarbodhmide
AR206201A1 (es)	1972-06-29	1976-07-07	Ciba Geigy Ag	Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos
GB1415910A (en) *	1973-03-21	1975-12-03	Kyowa Hakko Kogyo Kk	Benzothiazoles
DD110868A1 (es) *	1974-04-03	1975-01-12
GB1472052A (en) *	1975-02-14	1977-04-27	Pliva Pharm & Chem Works	Preparation of d-penicillamine and substituted 3-pyrazoline- 5-ones
GB1591439A (en)	1976-10-01	1981-06-24	Glaxo Operations Ltd	7-syn (oxyimino -acylamido) cephalosporins
DE2714880A1 (de)	1977-04-02	1978-10-26	Hoechst Ag	Cephemderivate und verfahren zu ihrer herstellung
US4128425A (en) *	1977-05-06	1978-12-05	Polaroid Corporation	Photographic developers
DD143617A1 (de)	1979-05-14	1980-09-03	Helmut Dorn	Verfahren zur herstellung von 2-nitro-und 2-amino-5-oxo-perhydro-pyrazolo eckige klammer auf 1,2-a eckige klammer zu pyrazolen
DE2931673A1 (de) *	1979-08-04	1981-02-26	Basf Ag	Pyrazolin-5-on-yl-methyl-(di)thiophosphorsaeureester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
GB2073740A (en) *	1980-03-03	1981-10-21	Wellcome Found	Pyrazolidinones
US4396619A (en)	1981-09-08	1983-08-02	Eli Lilly And Company	Cephalosporin betaines
GB2128984B (en) *	1982-05-12	1985-05-22	Hoffmann La Roche	Diaza-bicyclic compounds
US4465679A (en) *	1983-01-31	1984-08-14	Usv Pharmaceutical Corporation	1,2-Diaza-3-one compounds, their use in treating hypertension and pharmaceutical compositions thereof
AU575854B2 (en)	1983-10-04	1988-08-11	Shionogi & Co., Ltd.	7beta-(carboxyalkenamido) cephalosporins
KR890001150B1 (ko)	1985-04-30	1989-04-25	일라이 릴리 앤드 캄파니	디아졸리디논 유도체 및 그의 제조방법
IL78630A0 (en)	1985-04-30	1986-08-31	Lilly Co Eli	Pyrazolidinium ylides
DE3677253D1 (de) *	1985-04-30	1991-03-07	Lilly Co Eli	7-substituierte bicyclische pyrazolidinone.

1986
- 1986-04-28 DE DE8686303174T patent/DE3677253D1/de not_active Expired - Lifetime
- 1986-04-28 AT AT86303174T patent/ATE60605T1/de not_active IP Right Cessation
- 1986-04-28 ZA ZA863170A patent/ZA863170B/xx unknown
- 1986-04-28 KR KR1019860003251A patent/KR880001092B1/ko not_active Expired
- 1986-04-28 IL IL78634A patent/IL78634A0/xx unknown
- 1986-04-28 CN CN198686103619A patent/CN86103619A/zh active Pending
- 1986-04-28 EP EP86303174A patent/EP0202046B1/en not_active Expired - Lifetime
- 1986-04-28 GR GR861118A patent/GR861118B/el unknown
- 1986-04-28 AU AU56755/86A patent/AU5675586A/en not_active Abandoned
- 1986-04-28 DK DK193086A patent/DK193086A/da not_active Application Discontinuation
- 1986-04-28 ES ES554463A patent/ES8801833A1/es not_active Expired
- 1986-04-28 CA CA000507777A patent/CA1274832A/en not_active Expired - Lifetime
- 1986-04-28 HU HU861763A patent/HUT40660A/hu unknown
- 1986-04-28 PT PT82468A patent/PT82468B/pt unknown
- 1986-04-30 JP JP61100817A patent/JPH0759582B2/ja not_active Expired - Lifetime
- 1986-05-14 US US06/862,913 patent/US4716232A/en not_active Expired - Fee Related
- 1986-05-14 US US06/862,909 patent/US4734505A/en not_active Expired - Lifetime
- 1986-05-14 US US06/862,918 patent/US4734504A/en not_active Expired - Lifetime
- 1986-10-28 JP JP61258084A patent/JPS63112583A/ja active Pending
1987
- 1987-10-29 US US07/114,897 patent/US4795815A/en not_active Expired - Lifetime
1988
- 1988-04-13 ZA ZA882604A patent/ZA882604B/xx unknown

Also Published As

Publication number	Publication date
CN86103619A (zh)	1986-10-29
DK193086D0 (da)	1986-04-28
PT82468A (en)	1986-05-01
US4734505A (en)	1988-03-29
GR861118B (en)	1986-08-18
ES8801833A1 (es)	1988-02-16
HUT40660A (en)	1987-01-28
ZA882604B (en)	1989-12-27
KR860008181A (ko)	1986-11-12
DK193086A (da)	1987-01-20
EP0202046B1 (en)	1991-01-30
PT82468B (en)	1988-03-23
IL78634A0 (en)	1986-08-31
EP0202046A1 (en)	1986-11-20
CA1274832A (en)	1990-10-02
US4734504A (en)	1988-03-29
AU5675586A (en)	1986-11-13
US4716232A (en)	1987-12-29
ZA863170B (en)	1987-12-30
JPS63112583A (ja)	1988-05-17
ATE60605T1 (de)	1991-02-15
KR880001092B1 (ko)	1988-06-23
US4795815A (en)	1989-01-03
JPS61254589A (ja)	1986-11-12
DE3677253D1 (de)	1991-03-07
JPH0759582B2 (ja)	1995-06-28

Publication	Publication Date	Title
ES554463A0 (es)	1988-02-16	Un procedimiento para la preparacion de un compuesto.
YU17092A (sh)	1994-12-28	Derivati 2,4-diaminohinazolina
SE8201145L (sv)	1982-08-26	Nya aminometyl-5 oxazolidiniska derivat, deras framstellningssett och derasterapeutiska anvendning
ATE226574T1 (de)	2002-11-15	4,6-diarylpyrimidin-derivate und deren salze
BR9508608A (pt)	1997-12-30	Composto formulação farmacêutica e processo para prevenir ou tratar arritmia
FI940414A0 (fi)	1994-01-27	Kinoliini- tai kinatsoliinijohdannaiset, niiden valmistus ja käyttö
EA199800602A1 (ru)	1998-12-24	N-ацил-2-замещенный-4-(бензимидазолил- или имидазопиридинил -замещенные остатки)-пиперидины как антагонисты тахикинина
ZA929268B (en)	1993-06-29	Imidazole compounds, their preparation and use.
PT80507A (de)	1985-06-01	Neue substituierte bis-(4-aminophenyl)-sulfone ihre herstellungund ihre verwendung als arzneimittel
IL110055A (en)	1997-09-30	POSITIVE INOTROPIC AND LUSITROPIC 6-(SUBSTITUTED ALKOXY)-2, 3-DIHYDROPYRROLO£2,3-b\| QUINOLIN-2-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2000524A6 (es)	1988-03-01	Procedimiento para la preparacion de nuevas benzamidas y benzoatos sustituidos.
GB1092921A (en)	1967-11-29	Anthranilic acid derivatives
DE68923320D1 (de)	1995-08-10	Derivate von Aminsäuren.
DE69316392D1 (de)	1998-02-19	Azanoradamantane
ES2140445T3 (es)	2000-03-01	Derivados de pirrolidinil-tio-penem con propiedades antibioticas.
ES8304973A1 (es)	1983-03-16	Un procedimiento para la preparacion de nuevos derivados de tiocarbapenem 3-sustituidos.
YU63392A (sh)	1994-11-15	Bis(oksi) jedinjenja i postupak za njihovo dobijanje
DK428087A (da)	1987-08-17	Dihydropyridin-5-phosphonsyre-cyclopropylenester
MX9300281A (es)	1993-11-01	Metodo para la preparacion de acido 2,4,5-trihalobenzoico.
ATE208761T1 (de)	2001-11-15	Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungen
YU46886B (sh)	1994-06-24	Postupak za dobijanje haloalkil tiazola
GB1105492A (en)	1968-03-06	Improvements in or relating to novel 3-tropanyl 2-phenylacrylate derivatives
ES8502999A1 (es)	1985-02-16	Procedimiento para preparar acidos 5-aroil-6-alcohiltio-1,2, dihidro-3h-pirrolo 1,2-a pirrol-1-carboxilicos
NZ337605A (en)	2001-03-30	Process for preparing trovafloxacin acid salts
YU13197A (sh)	1999-09-27	Novi 2,3-benzodiazepinski derivati, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže